Peripheral arterial disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
== Age == | == Age == | ||
*The incidence of peripheral arterial disease increases with increasing age<ref name=3rx>{{cite web | author = | title =Peripheral arterial disease prevention and prevalence | work =Peripheral Arterial Disease | url=http://www.3-rx.com/ab/more/peripheral-arterial-disease-prevention-and-prevalence/ | year = 2007 | month= Nov 1 | publsiher=Your Health Encyclopedia | accessdate=2007-12-03}}</ref> | *The incidence of peripheral arterial disease increases with increasing age<ref name=3rx>{{cite web | author = | title =Peripheral arterial disease prevention and prevalence | work =Peripheral Arterial Disease | url=http://www.3-rx.com/ab/more/peripheral-arterial-disease-prevention-and-prevalence/ | year = 2007 | month= Nov 1 | publsiher=Your Health Encyclopedia | accessdate=2007-12-03}}</ref> | ||
* The incidence of symptomatic PVD increases with age, from about 0.3% per year for men aged 40–55 years to about 1% per year for men aged over 75 years. The prevalence of PVD varies considerably depending on how PAD is defined, and the age of the population being studied.<ref name="3rx" /> Diagnosis is critical, as people with PAD have a four to five times higher risk of [[Myocardial infarction|heart attack]] or [[stroke]]. | |||
The incidence of symptomatic PVD increases with age, from about 0.3% per year for men aged 40–55 years to about 1% per year for men aged over 75 years. The prevalence of PVD varies considerably depending on how PAD is defined, and the age of the population being studied.<ref name="3rx" /> Diagnosis is critical, as people with PAD have a four to five times higher risk of [[Myocardial infarction|heart attack]] or [[stroke]]. | * In Western Australia, the prevalence of symptomatic disease at around 60 years of age is about 5%.<ref name=ncbi>{{cite web | author = Hiatt W, Hoag S, Hamman R. | title =Effect of diagnostic criteria on the prevalence of peripheral arterial disease | work =Effect of diagnostic criteria on the prevalence of peripheral arterial disease | url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7867189&dopt=Abstract | year = 1995 | month= Sep 21 | publsiher=Circulation 1995; 91: 1472-1479 | accessdate=2007-12-03}}</ref> | ||
In Western Australia, the prevalence of symptomatic disease at around 60 years of age is about 5%.<ref name=ncbi>{{cite web | author = Hiatt W, Hoag S, Hamman R. | title =Effect of diagnostic criteria on the prevalence of peripheral arterial disease | work =Effect of diagnostic criteria on the prevalence of peripheral arterial disease | url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7867189&dopt=Abstract | year = 1995 | month= Sep 21 | publsiher=Circulation 1995; 91: 1472-1479 | accessdate=2007-12-03}}</ref | |||
The Diabetes Control and Complications Trial and U.K. Prospective Diabetes Study trials in people with type 1 and type 2 diabetes, respectively, demonstrated that glycemic control is more strongly associated with microvascular disease than macrovascular disease. It may be that pathologic changes occurring in small vessels are more sensitive to chronically elevated glucose levels than is atherosclerosis occurring in larger arteries.<ref name=diabetesjournals>{{cite web | author = Elizabeth Selvin, PHD, MPH, Keattiyoat Wattanakit, MD, MPH, Michael W. Steffes, MD, PHD, Josef Coresh, MD, PHD and A. Richey Sharrett, MD, DRPH | title =HbA1c and Peripheral Arterial Disease in Diabetes | work =The Atherosclerosis Risk in Communities study | url=http://care.diabetesjournals.org/cgi/content/full/29/4/877 | year = 2005 | month= Oct 20 | publsiher=Diabetes Care | accessdate=2007-12-03}}</ref> | The Diabetes Control and Complications Trial and U.K. Prospective Diabetes Study trials in people with type 1 and type 2 diabetes, respectively, demonstrated that glycemic control is more strongly associated with microvascular disease than macrovascular disease. It may be that pathologic changes occurring in small vessels are more sensitive to chronically elevated glucose levels than is atherosclerosis occurring in larger arteries.<ref name=diabetesjournals>{{cite web | author = Elizabeth Selvin, PHD, MPH, Keattiyoat Wattanakit, MD, MPH, Michael W. Steffes, MD, PHD, Josef Coresh, MD, PHD and A. Richey Sharrett, MD, DRPH | title =HbA1c and Peripheral Arterial Disease in Diabetes | work =The Atherosclerosis Risk in Communities study | url=http://care.diabetesjournals.org/cgi/content/full/29/4/877 | year = 2005 | month= Oct 20 | publsiher=Diabetes Care | accessdate=2007-12-03}}</ref> | ||
==References== | ==References== | ||
Revision as of 01:09, 31 October 2012
Editors-in-Chief: C. Michael Gibson, Robert G. Schwartz, M.D. [1], Piedmont Physical Medicine and Rehabilitation, P.A.; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
The prevalence of peripheral arterial disease in the general population is 12–14%. Peripheral arterial disease is even more common among the elderly and affects up to 20% of patients over the age of 70 years [1]. Peripheral vascular disease affects 1 in 3 diabetics over the age of 50. Approximately 10 million Americans have peripheral arterial disease.
Age
- The incidence of peripheral arterial disease increases with increasing age[2]
- The incidence of symptomatic PVD increases with age, from about 0.3% per year for men aged 40–55 years to about 1% per year for men aged over 75 years. The prevalence of PVD varies considerably depending on how PAD is defined, and the age of the population being studied.[2] Diagnosis is critical, as people with PAD have a four to five times higher risk of heart attack or stroke.
- In Western Australia, the prevalence of symptomatic disease at around 60 years of age is about 5%.[3]
The Diabetes Control and Complications Trial and U.K. Prospective Diabetes Study trials in people with type 1 and type 2 diabetes, respectively, demonstrated that glycemic control is more strongly associated with microvascular disease than macrovascular disease. It may be that pathologic changes occurring in small vessels are more sensitive to chronically elevated glucose levels than is atherosclerosis occurring in larger arteries.[4]
References
- ↑ Shammas NW (2007). "Epidemiology, classification, and modifiable risk factors of peripheral arterial disease". Vascular Health and Risk Management. 3 (2): 229–34. PMC 1994028. PMID 17580733.
- ↑ 2.0 2.1 "Peripheral arterial disease prevention and prevalence". Peripheral Arterial Disease. 2007. Retrieved 2007-12-03. Unknown parameter
|publsiher=ignored (|publisher=suggested) (help); Unknown parameter|month=ignored (help) - ↑ Hiatt W, Hoag S, Hamman R. (1995). "Effect of diagnostic criteria on the prevalence of peripheral arterial disease". Effect of diagnostic criteria on the prevalence of peripheral arterial disease. Retrieved 2007-12-03. Unknown parameter
|publsiher=ignored (|publisher=suggested) (help); Unknown parameter|month=ignored (help) - ↑ Elizabeth Selvin, PHD, MPH, Keattiyoat Wattanakit, MD, MPH, Michael W. Steffes, MD, PHD, Josef Coresh, MD, PHD and A. Richey Sharrett, MD, DRPH (2005). "HbA1c and Peripheral Arterial Disease in Diabetes". The Atherosclerosis Risk in Communities study. Retrieved 2007-12-03. Unknown parameter
|publsiher=ignored (|publisher=suggested) (help); Unknown parameter|month=ignored (help)